INGN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
77.2M
-18.8%
95.1M
+11.7%
85.1M
+4.1%
81.7M
+3.3%
79.1M
Cost of Revenue
43.2M
-16.7%
51.8M
+9.7%
47.2M
+1.6%
46.5M
+8.3%
42.9M
Gross Profit
34.0M
-21.4%
43.3M
+14.3%
37.9M
+7.5%
35.2M
-2.6%
36.2M
Operating Expenses
49.6M
+2.5%
48.4M
+2.5%
47.2M
+6.0%
44.5M
+7.1%
41.6M
R&D
5.4M
-8.0%
5.9M
+15.2%
5.1M
-4.1%
5.3M
+9.8%
4.8M
SG&A
33.6M
-20.9%
42.5M
+0.9%
42.1M
+7.3%
39.2M
+6.7%
36.8M
Operating Income
-15584000
-205.8%
-5096000
+45.4%
-9336000
-0.3%
-9306000
-71.2%
-5435000
EBITDA
-8017000
-1909.3%
-399000
+91.0%
-4432000
-3.8%
-4271000
+53.7%
-9231000
Net Income
-16155000
-319.6%
-3850000
+53.7%
-8324000
-16.8%
-7127000
-34.6%
-5294000
EPS (Basic)
$-0.61
-335.7%
$-0.14
+53.3%
$-0.30
-15.4%
$-0.26
-30.0%
$-0.20
EPS (Diluted)
$-0.61
-335.7%
$-0.14
+53.3%
$-0.30
-15.4%
$-0.26
-30.0%
$-0.20
Shares (Diluted)
26.5M
-2.2%
27.0M
-1.0%
27.3M
+0.4%
27.2M
+0.5%
27.1M
Inogen (INGN) — Financials